Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia: A stable isotope study

Journal of Lipid Research

Volumn 40, Issue 8, 1999, Pages 1506-1511

  Frenais R ^a   Ouguerram, K ^a   Maugeais, C ^a   Marchini, J S ^d   Benlian, P ^b   Bard, J M ^a   Magot, T ^a   Krempf, M ^a,c  

^a HÔTEL DIEU   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c Clinique d'Endocrinologie Hotel Dieu CHU de Nantes   (France)

^d NONE

Author keywords

Apo AI; HDL; Heterozygous familial hypercholesterolemia; Kinetic analysis; Stable isotope

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEEDBACK SYSTEM; FEMALE; GENE CONTROL; HETEROZYGOTE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; DEUTERIUM; FEMALE; GENE EXPRESSION REGULATION; HETEROZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; RECEPTORS, LDL;

EID: 0345465926     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Streja, D., G. Steiner, and P. O. Kwiterovich. 1978. Plasma high density lipoproteins and ischemic heart disease: studies in a large kindred with familial hypercholesterolemia. Ann. Intern. Med. 89: 871-880.
2. Gordon, T., W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber. 1977. High density lipoprotein as a protective factor against coronary heart disease: the Framingham study. Am. J. Med. 62: 707-714.
3. Gordon, D. J., and B. M. Rifkind. 1989. High density lipoprotein: the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
4. Goldstein, J. L., and M. S. Brown. 1983. Familial hypercholesterolemia. In The Metabolic Basis of Inherited Disease. J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson, J. L. Goldstein, and M. S. Brown, editors. McGraw-Hill Book Co., New York. 672-712.
5. Fisher, W. R., L. A. Zech, and P. W. Stacpoole. 1994. Apo B metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm. Arterioscler. Thromb. 14: 501-510.
6. Shepherd, J., and C. J. Packard. 1989. Lipoprotein metabolism in familial hypercholesterolemia. Arteriosclerosis. 9: 139-142.
7. Stangl, H., G. Cao, K. L. Wyne, H. H. Hobbs. 1998. Scavenger receptor, class B, type I-dependent stimulation of cholesterol esterification by high density lipoproteins, low density lipoproteins, and nonlipoprotein cholesterol. J. Biol. Chem. 273: 31002-31008.
8. Arai, T., N. Wang, M. Bezouevski, C. Welch, and A. R. Tall. 1999. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J. Biol. Chem. 274: 2366-2371.
9. Wang, N., T. Arai, Y. Ji, F. Rinninger, and A. R. Tall. 1998. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein apoB, low density lipoprotein apo B, and high density lipoprotein in transgenic mice. J. Biol. Chem. 273: 32920-32926.
10. Schaefer, J. R., D. J. Rader, K. Ikewaki, T. Fairwell, L. A. Zech, M. R. Kindt, J. Davignon, R. E. Gregg, H. B. Brewer, Jr. 1992. In vivo metabolism of apolipoprotein AI in a patient with homozygous familial hypercholesterolemia. Arterioscler. Thromb. 12: 843-848.
11. Malmendier, C. L., and C. Delcroix. 1985. Effects of fenofibrate on high and low density lipoprotein metabolism in heterozygous familial hypercholesterolemia. Atherosclerosis. 55: 161-169.
12. Fidge, N., P. Nestel, T. Ishikawa, M. Reardon, and T. Billington. 1980. Turnover of apoprotein A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals. Metabolism. 29: 643-653.
13. Benlian, P., J. L. De Gennes, F. Dairou, B. Hermelin, I. Ginon, E. Villain, J. P. Lagarde, M. C. Federspiel, V. Bertrand, C. Bernard, and G. Bereziat. 1996. Phenotypic expression in double heterozygotes for familial hypercholesterolemia and familial defective apolipoprotein B-100. Hum. Mutat. 7: 340-345.
14. Frénais, R., K. Ouguerram, C. Maugeais, P. Mahot, P. Maugère, M. Krempf, and T. Magot. 1997. High density lipoprotein apolipoprotein A-I kinetics in NIDDM: a stable isotope study. Diabetologia. 40: 578-583.
15. Chapman, M. J., S. Goldstein, D. Lagrange, and P. M. Laplaud. 1981. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J. Lipid Res. 22: 339-358.
16. Dagher, F. J., J. H. Lyons, D. C. Finlayson, J. Shamsai, and F. D. Moore. 1965. Blood volume measurement : a critical study. Prediction of normal values, controlled measurement of sequential changes, choice of a bedside method. Adv. Surg. 1: 69-109.
17. Schaefer, E. J., L. A. Zech, L. L. Jenkins, T. J. Bronzert, E. A. Rubalcaba, F. T. Lindgren, R. L. Aamodt, and H. B. Brewer, Jr. 1982. Human apolipoprotein A-I and A-II metabolism. J. Lipid Res. 23: 850-862.
18. Foster, D. M., P. H. R. Barrett, G. Toffolo, W. F. Beltz, and C. Cobelli. 1993. Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data. J. Lipid Res. 34: 2193-2205.
19. Ikewaki, K., D. J. Rader, J. R. Schaefer, T. Fairwell, L. A. Zech, H. B. Brewer, Jr. 1993. Evaluation of apoA-I kinetics in human using simultaneous endogenous stable isotope and exogenous radiotracer methods. J Lipid Res. 34: 2207-2215.
20. Kajinami, K., H. Mabuchi, J. Koizumi, and R. Takeda. 1992. Serum apolipoprotein in heterozygous familial hypercholesterolemia. Clin. Chim. Acta. 211: 93-99.
21. Guérin, M., P. J. Dolphin, and M. J. Chapman. 1994. Preferential cholesteryl ester acceptors among the LDL subspecies of subjects with familial hypercholesterolemia. Arterioscler. Thromb. 14: 679-685.
22. Schaefer, J. R., D. J. Rader, H. B. Brewer, Jr. 1992. Investigation of lipoprotein kinetics using endogenous labeling with stable isotopes. Curr. Opin. Lipidol. 3: 227-232.
23. Barrett, P. H. R., and D. M. Foster. 1996. Design and analysis of lipid tracer kinetic studies. Curr. Opin. Lipidol. 7: 143-148.
24. Patterson, B. W. 1997. Use of stable isotopically labeled tracers for studies of metabolic kinetics: an overview. Metabolism. 46: 322-329.
25. Osborne, J. C., E. J. Schaefer, G. M. Powell, N. S. Lee, and L. A. Zech. 1984. Molecular properties of radioiodinated apolipoprotein A-I. J Biol. Chem. 259: 347-353.
26. Walsh, B. W., H. Li, and F. M. Sacks. 1994. Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J. Lipid Res. 35: 2083-2093.
27. Lichtenstein, A. H., J. S. Cohn, D. L. Hachey, J. S. Millar, J. M. Ordovas, and E. J. Schaefer. 1990. Comparison of deuterated leucine, valine, and lysine in the measurement of human apolipoprotein A-I and B-100 kinetics. J. Lipid Res. 31: 1693-1701.
28. Ikewaki, K., D. J. Rader, T. Sakamoto, M. Nishiwaki, J. R. Schaefer, T. Ishikawa, T. Fairwell, L. A. Zech, H. Nakamura, M. Nagano, and H. B. Brewer, Jr. 1993. Delayed catabolism of high density lipoprotein A-I and A-II in human cholesleryl ester transfer protein deficiency. J. Clin. Invent. 92: 1650-1658.
29. Schaefer, E. J., D. M. Foster, L. L. Jenkins, F. T. Lindgren, M. Berman, R. I. Levy, and H. B. Brewer, Jr. 1979. The composition and metabolism of high density lipoprotein subfractions. Lipids. 14: 511-522.
30. Guérin, M., P. J. Dolphin, C. Talussot, J. Gardette, F. Berlhézène, and M. J. Chapman. 1995. Pravastatin modulates cholesteryl ester transfer from HDL to apoB-comaining lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 15: 1359-1368.
31. Brinton, E. A., S. Eisenberg, and J. L. Breslow. 1991. Increased apoA-I and apoA-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J. Clin. Invest. 87: 536-544.
32. Horowitz, B. S., I. J. Goldberg, J. Merab, T. M. Vanni, R. Ramakrishnan, and H. N. Ginsberg. 1993. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J. Clin. Invest. 91: 1743-1752.
33. Inazu, A., J. Koizumi, H. Mabuchi, K. Kajinami, and R. Takeda. 1992. Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia. Horm. Metab. Res. 24: 284-288.
34. Kwiterovich, P. O., D. S. Fredrickson, and R. I. Levy. 1974. Familial Hypercholeslerolemia (one form of familial type II hyperlipoproteinemia): a study of its biochemical, genetic, and clinical presentation in childhood. J. Clin. Invest. 53: 1237-1249.
35. Moorjani, S., C. Gagné, P. J. Lupien, and D. Brun. 1986. Plasma triglycerides related decrease in high density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia. Metabolism. 35: 311-316.
36. Pimstone, S. N., S. E. Gagné, C. Gagné, P. J. Lupien, D. Gaudet, R. R. Williams, M. Kotze, P. W. A. Reymer, J. C. Defesche, J. J. P. Kastelein, S. Moorjani, and M. R. Hayden. 1995. Mutations in the gent for lipoprotein lipase. A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia. Arteroscler. Thromb. Vasc. Biol. 15: 1704-1712.
37. Saku, K., K. Yamamoto, T. Sakai, T. Yanagida, K. Hidaka, J. Sasaki, and K. Arakawa. 1989. Kinetics of HDL-apoA-I in the WHHL rabbit, an animal model of familial hypercholesterolemia. Atherosclerosis. 79: 225-230.
38. Gairin, D., F. Monard, C. Cachera, J. M. Bard, P. Amouyel, P. Duriez, A. Tacquet, and J. C. Fruchart. 1990. Lipoprotein particles in homozygous familial hypercholesterolemia patients treated with portacaval shunt and LDI. apheresis. Clin. Chim. Acta. 193: 165-180.
39. Goldberg, R. B., G. M. Fless, S. G. Baker, B. I. Joffe, G. S. Getz, A. M. Scanu, and H. C. Seftel. 1984. Abnormalities of high density lipoproteins in homozygous familial hypercholesterolemia. Arteriosclerosis. 4: 472-478.
40. Monge, J. C., J. M. Hoeg, S. W. Law, H. B. Brewer, Jr. 1989. Effect of low density lipoproteins, high density lipoproteins, and cholesterol on apolipoprotein A-I mRNA in Hep G2 cells. FEBS Lett. 243: 213-217.